Alkali Metals share news and announcements
NSE: ALKALIBSE: 533029Chemicals & PetrochemicalsSmall Cap
Last close ₹77.87down ₹3.55 (4.36%)BSE ₹76.05
Share price at the NSE close on 23 Oct 2026. Previous close ₹81.42.
52-week range of traded prices to 23 Oct 2026
₹46.80Low, 30 Mar 2026₹106.30High, 22 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹79 Cr3,148th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Oct 2026
- 31.0
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 Oct 2026
- 1.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.28%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Oct 2026
- 6.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Oct 2026
- 6.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026. The filing of 12 Oct 2026
- 0.48
- Volume, NSEVolume. Shares traded on the last trading day.
- 3,053
Alkali Metals share news and announcements
381 announcements, routine notices left out, newest first. Page 8 of 8.
Nov 2010
2 Nov · Board meeting
Inter-alia amongst other items consider, publish and take on record the Un-Audited Financial Results for the second quarter ended September 30, 2010.
Sep 2010
8 Sep · Updates
The Board in its meeting held on September 08, 2010 has proposed to make/participate in bidding process for setting up of 5 MW Solar Power Project under Phase I of JNNSM, issued by NTPC Vidyut Vyapar Nigam Limited, New Delhi
Jul 2010
30 Jul · Meeting
In Annual General Meeting of the Company held on July 30, 2010 the members have considered and approved the Annual Accounts for the year ended March 31, 2010. Further, the major outcome of the meeting is as follows : (1) The shareholders approved payment of dividend at 40% (i.e. Rs.4/-) on Equity shares of Rs. 10/- each; (2) The shareholders have re-elected Dr. J.S. Yadav, Sri. P.C. Patnaik and Smt. Y. Lalithya Poorna as Directors of the Company; (3) M/s. CKS Associates, Chartered Accountants, Hyderabad were appointed as Auditors of the Company for the year 2010-11; (4) Sri. Y.S.R. Venkata Rao was re-appointed as Managing Director of the Company.21 Jul · Board meeting
To consider and take on record the Un-audited Financial Results of the Company for the 1st quarter ended June 30, 2010.5 Jul · Meeting
Register of Members of the Company will remain closed with effect from July 28, 2010 to July 30, 2010 (both days inclusive) for the purpose of Annual General Meeting to be held on July 30, 2010 and for payment of dividend if approved by Members in the said meeting.
May 2010
28 May · Dividend
Board of Directors at their meeting held on May 27, 2010 recommended the dividend of Rs.4/- per share of Rs. 10/- each (i.e. 40%), subject to approval of shareholders at the Annual General Meeting.27 May · Management
(1) Dr. J.S. Yadav, Independent Director (Director - Indian Institute of Chemical Technology, Hyderabad) has been elected as Chairman of the Company; (2) Smt. Y. V. Lalitha Devi, Chairperson & Promoter Director and Smt. Y. Krishna Veni, Promoter Director and Additional Director, have resigned from the Board.18 May · Board meeting
To consider interalia amongst other things take on record the Audited Financial Results of the Company for the fourth quarter and year ended March 31,2010 and to consider recommendation of Dividend if any, for the year ended March 31, 2010 and to fix the date, time and venue of the Annual General Meeting.
Apr 2010
19 Apr · Board meeting
Company in its Board Meeting held on April 10, 2010 has decided the following Matters: (1) The Board paid its rich tributes to Dr. YVSS Murty, Founder Chairman and also passed a resolution recording its high esteem to the departed soul, (2) The Board considered in principle on re-appointment of Mr. YSR Venkata Rao, as Managing Director and the terms of appointment will be decided in next meeting to be held in May 2010, (3) Smt. Y. Krishna Veni and Smt. Y. Lalithya Poorna were appointed as Additional Directors pursuant to Section 260 of the Companies Act, 1956 and Article 8g of Article of Association of the Company for the vacancy caused due to sudden demise of Dr. YVSS Murty. These promoter Directors were inducted to meet the requirements of the Corporate Governance.5 Apr · Board meeting
To consider amongst other items : 1) Pass a condolence Resolution for the sad demise of Dr. Y.V.S.S. Murty, Founder Chairman and record its high esteem for the best services rendered by him. 2) To consider the terms of re-appointment of Sri. YSR Venkata Rao, Managing Director.1 Apr · Demise
Company's Founder Chairman and Director Dr. Y. V. S. S. Murty, has passed away on March 30, 2010 in Hyderabad, Andhra Pradesh.
Mar 2010
16 Mar · Updates
Company has started its Commercial operations w.e.f. March 16, 2010 from its parwada unit, Visakhapatnam, Andhra Pradesh.
Feb 2010
12 Feb · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on January 29, 2010) that: "Deployment of Funds raised from IPO up to the December 31, 2009 is as follows:- (a) Setting up a new plant at Vizag for manufacturing of Active Pharmaceutical Ingredients under progress:- As per prospectus: 387.37 (Rs. million); Actual: 194.89 (Rs. million); (b) Issue expenses:- As per prospectus: 24.75 (Rs. million); Actual: 24.75 (Rs. million). Balance of IPO funds are invested in Mutual funds and partly reduced the availment of working capital facility as stipulated in prospectus".
Jan 2010
20 Jan · Board meeting
Meeting on 29 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
29 Oct · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended September 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on October 29, 2009) that: "Deployment of Funds raised from IPO up to the September 30, 2009 is as follows:- (a) Setting up a new plant at Vizag for manufacturing of Active Pharmaceutical Ingredients under progress:- As per prospectus: 387.37 (Rs. million); Actual: 174.55 (Rs. million); (b) Issue expenses:- As per prospectus: 24.75 (Rs. million); Actual: 24.75 (Rs. million). Balance of IPO funds are invested in Mutual funds and partly reduced the availment of working capital facility as stipulated in prospectus".21 Oct · Board meeting
Meeting on 29 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Aug 2009
3 Aug · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended June 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on July 29, 2009) that: "Deployment of Funds raised from IPO up to the June 30, 2009 is as follows:- (a) Setting up a new plant at Vizag for manufacturing of Active Pharmaceutical Ingredients under progress:- As per prospectus: 387.37 (Rs. million); Actual: 148.09 (Rs. million); (b) Issue expenses:- As per prospectus: 24.75 (Rs. million); Actual: 24.75 (Rs. million). Balance of IPO funds are invested in Mutual funds and partly reduced the working capital facility as stipulated in prospectus".
Jul 2009
20 Jul · Board meeting
Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
Jun 2009
8 Jun · Meeting
Minutes of the Annual General Meeting of the Company held on May 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.8 Jun · Meeting
Outcome of Annual General Meeting of the Company held on May 30, 2009 is as follows: (1) The shareholders approved payment of dividend at 40% on Equity shares of Rs.10/- each. (2) The shareholders re-appointed Sri. Ch. S. Prasad and Sri. G. Jayaraman as Directors of the Company. (3) M/s. CKS Associates, Chartered Accountants, Hyderabad were appointed as Auditors of the Company for the year 2009-10 in place of M/s. Avadhani & Co., Hyderabad who retired at the Annual General Meeting. (4) Sri. Y. S. R. Venkata Rao was re-appointed as Managing Director of the Company.
May 2009
7 May · Meeting
Register of Members will remain Closed with effect from May 27, 2009 to May 30, 2009 for the purpose of Annual General Meeting to be held on May 30, 2009 and to record the List of eligible shareholders for payment of dividend as may be approved by Members in the said meeting.4 May · Disclosure
Disclosure pursuant to Regulation 8A(4) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 1997. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Apr 2009
20 Apr · Utilisation of Funds
Vide notes to Accounts in the Financial Results for the three/ Twelve months ended March 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on April 17, 2009) that: "Deployment of funds raised from IPO up to the March 31, 2009 is as follows:- (a) Setting up a new plant at Vizag for manufacturing of Active Pharmaceutical Ingredients under progress:- As per prospectus: 387.37 (Rs. million); Actual: 140.69 (Rs. million); (b) Issue expenses:- As per prospectus: 24.75 (Rs. million); Actual: 24.75 (Rs. million). Balance of IPO funds are invested in Mutual funds and partly reduced the working capital facility as stipulated in prospectus".20 Apr · Board meeting
Following intimation on the outcome of the Board meeting held on April 17, 2009: (1) It is proposed to hold Annual General Meeting on May 30, 2009. (2) The Statutory Auditors M/s. Avadhani & Co., have tendered their resignation from the conclusion of the Annual General Meeting and they expressed their willingness to continue as Internal Auditors. (3) The Board proposed to appoint M/s. C K S Associates, Chartered Accountants, Hyderabad as statutory auditors.20 Apr · Dividend
Following information on the outcome of the Board meeting held on April 17, 2009: Recommended Dividend at 40% on the equity shares (Rs. 10/- paid-up) of the company for the year 2008-09 subject to approval in the Annual General Meeting.13 Apr · Board meeting
To consider: (1) To approve and take on record the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2009 and to publish the same (2) To recommend Dividend if any, for the year ended March 31, 2009 (3)Re-appointment of Sri. Y. S. R. Venkata Rao, Managing Director (4)To fix the date, time and venue of the Annual General Meeting.
Mar 2009
20 Mar · Management
Company has appointed Mr P. Satish Chandra Mouli, M.Com, LL.B, FCS, as Company Secretary and Compliance Officer as per Clause 47(a) of the Listing Agreement.
Jan 2009
27 Jan · Utilisation of Funds
Vide notes to Accounts in the Unaudited Financial Results for the quarter ended December 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on January 22, 2009) that: "Deployment of funds raised from IPO up to the December 31, 2008 is as follows:- (a) Setting up a new plant at Vizag for manufacturing of Active Pharmaceutical Ingredients under progress:- As per prospectus: 387.37 (Rs. million); Actual: 104.09 (Rs. million); (b) Issue expenses:- As per prospectus: 24.75 (Rs. million); Actual: 24.75 (Rs. million)".14 Jan · Board meeting
Meeting on 22 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Nov 2008
19 Nov · Management
Mr. Vasudeva Rao Devaki, Company Secretary and Compliance Officer of the company is resigned from the Company and he is discharged from the duties with effect from 18th November 2008. We further inform that we are in the process of appointing another Company Secretary in the place of the resigned Company Secretary